|
Forecast
Period
|
2024-2028
|
|
Market
Size (2022)
|
USD
8.35 billion
|
|
CAGR
(2023-2028)
|
6.10%
|
|
Fastest
Growing Segment
|
Surgical Scopes
|
|
Largest
Market
|
United
States
|
Market Overview
North
America Minimally Invasive Surgical Devices Market has valued at USD 8.35
billion in 2022 and is anticipated to project robust growth in the forecast
period with a CAGR of 6.10% through 2028. The North America Minimally Invasive
Surgical Devices Market is a dynamic and rapidly evolving sector within the
broader healthcare industry. It encompasses a wide range of medical devices and
technologies designed to facilitate surgical procedures with minimal
invasiveness.
The
North America Minimally Invasive Surgical Devices Market is one of the largest
and most mature markets globally. It comprises the United States and Canada,
two countries known for their advanced healthcare infrastructure and technology
adoption. The market has experienced consistent growth over the years, driven
by factors such as technological advancements, increasing demand for less
invasive procedures, and a growing aging population. The market's size and
growth are influenced by the prevalence of various medical conditions that
require surgical interventions, as well as the adoption of minimally invasive
techniques across a wide spectrum of medical specialties.
Key Market Drivers
Advancements
in Technology and Innovation
Advancements
in technology and innovation play a pivotal role in driving the growth of the
North America Minimally Invasive Surgical Devices Market. These advancements
have revolutionized the field of healthcare by enabling healthcare providers to
perform surgeries with greater precision, reduced invasiveness, and improved
patient outcomes. the most transformative innovation in minimally invasive
surgery is the development of robotic-assisted surgical systems, such as the da
Vinci Surgical System. These systems use advanced robotics and real-time
imaging to provide surgeons with enhanced control and precision during
procedures. Robotic-assisted surgery allows for smaller incisions, reduced
blood loss, and shorter recovery times. Surgeons can perform complex surgeries
with greater accuracy, even in hard-to-reach areas of the body. This technology
has been widely adopted in various surgical specialties, including urology,
gynecology, and general surgery.
The
integration of three-dimensional (3D) imaging and visualization technologies
has significantly improved the surgeon's ability to visualize and navigate
inside the patient's body. High-definition 3D imaging provides a more detailed
and immersive view during minimally invasive procedures. Surgeons can assess
anatomy with greater precision, identify abnormalities, and make more informed
decisions during surgery. This has led to improved surgical outcomes and a
reduction in complications. Advances in materials science and engineering have
enabled the development of smaller, more precise surgical instruments. These
miniaturized tools can be used through tiny incisions or ports in minimally
invasive procedures. Miniaturization allows for greater dexterity and control,
facilitating delicate and intricate surgical tasks. Surgeons can manipulate
tissues and organs with greater precision, reducing the risk of damage and
improving patient safety.
The
integration of telemedicine and remote surgery capabilities has expanded the
reach of minimally invasive surgical procedures. Surgeons can now perform
surgeries on patients who are located remotely, potentially even in different
cities or countries. This innovation has been particularly valuable in
situations where specialized expertise is required but not readily available
locally. Telemedicine and remote surgery have the potential to democratize
access to high-quality surgical care.
Increasing
Prevalence of Chronic Diseases
The
increasing prevalence of chronic diseases is a significant market driver that
fuels the growth of the North America Minimally Invasive Surgical Devices
Market. Chronic diseases are characterized by long-lasting and persistent
health conditions that often require medical intervention, including surgical
procedures. Cardiovascular diseases, such as coronary artery disease, heart
failure, and arrhythmias, are among the leading causes of morbidity and
mortality in North America. These conditions often necessitate surgical
interventions to restore blood flow or repair cardiac structures. Minimally
invasive approaches, such as angioplasty and stent placement, have become
standard procedures for treating cardiovascular diseases. These methods involve
smaller incisions, reduced trauma to the patient, and shorter recovery times,
driving their adoption.
The
prevalence of obesity has reached epidemic proportions in North America,
leading to various health issues like type 2 diabetes, hypertension, and joint
problems. Bariatric surgeries, such as gastric bypass and sleeve gastrectomy,
are commonly performed to help patients manage obesity and its associated
comorbidities. Minimally invasive techniques in bariatric surgery, such as
laparoscopic procedures, have gained popularity due to their reduced
post-operative pain and quicker return to normal activities. As obesity rates
continue to rise, the demand for these surgeries and associated devices grows.
Chronic
gastrointestinal conditions, including Crohn's disease, ulcerative colitis, and
diverticulitis, often require surgical interventions to alleviate symptoms or
address complications. Minimally invasive techniques, such as laparoscopy, have
become the preferred choice for many of these procedures. Minimally invasive
surgeries in the gastrointestinal field offer benefits like smaller incisions,
reduced risk of infection, and shorter hospital stays, which appeal to both
patients and healthcare providers. As the aging population in North America
increases, so does the prevalence of orthopedic conditions like osteoarthritis
and degenerative disc disease. These conditions often lead to joint pain and
the need for joint replacement surgeries. Minimally invasive techniques in
orthopedic surgery, such as arthroscopy and minimally invasive spine surgery,
have gained traction due to their ability to preserve healthy tissue, reduce
scarring, and accelerate recovery.
Aging
Population
The
aging population is a significant market driver that contributes to the growth
of the North America Minimally Invasive Surgical Devices Market. As the
demographic composition of North America shifts towards an older population,
there is an increased demand for healthcare services, including surgical
procedures. As individuals age, they are more likely to develop chronic health
conditions, degenerative diseases, and age-related ailments. Many of these
conditions require surgical intervention for diagnosis, treatment, or symptom
management. Older adults often prefer minimally invasive surgical procedures
because they offer several advantages, including reduced trauma to the body,
shorter hospital stays, and faster recovery times. The demand for these less
invasive techniques is therefore higher among the aging population.
Aging
is often associated with joint-related issues such as osteoarthritis and joint
degeneration. Joint replacement surgeries, such as hip and knee replacements,
are common among older adults to restore mobility and alleviate pain. Minimally
invasive techniques in orthopedic surgery, such as minimally invasive hip and
knee replacements, have gained popularity among older patients due to their
less invasive nature and quicker rehabilitation.
Cardiovascular
diseases, including coronary artery disease and heart valve disorders, become
more prevalent with age. These conditions may necessitate surgical
interventions, such as angioplasty or valve replacement. Minimally invasive
approaches in cardiovascular surgery, such as percutaneous coronary
interventions and transcatheter aortic valve replacements (TAVR), are preferred
among older patients due to reduced risks associated with open heart surgery. The
risk of cancer increases with age, and older adults often require surgical
procedures for cancer diagnosis and treatment. Minimally invasive approaches,
such as laparoscopy and robotic-assisted surgery, have become standard in
oncology. Minimally invasive techniques are particularly valuable for older
patients, as they reduce the physical stress associated with surgery, making it
a more viable option for those with age-related frailty. Minimally invasive
surgical devices are well-suited for the elderly population as they minimize
trauma, reduce recovery times, and lower the risk of complications. As the
aging population continues to grow, the demand for these devices is expected to
increase.
Healthcare
Cost Containment
Healthcare
cost containment is a crucial market driver that significantly influences the
growth of the North America Minimally Invasive Surgical Devices Market. As
healthcare costs continue to rise, healthcare providers, payers, and
institutions seek cost-effective solutions, and minimally invasive surgical
techniques align with this objective. Minimally invasive surgical procedures
typically require shorter hospital stays compared to traditional open
surgeries. Patients can often be discharged sooner, leading to lower
hospitalization costs.
Hospitals
and healthcare institutions are incentivized to adopt minimally invasive
techniques to reduce the financial burden associated with longer
hospitalizations, including costs related to patient care, bed occupancy, and
facility resources. Minimally invasive surgeries often result in faster
recoveries, which, in turn, reduce the need for extended post-operative care.
Patients may require fewer outpatient visits and home healthcare services. Healthcare
cost containment strategies emphasize the importance of minimizing ongoing
healthcare expenses. Minimally invasive surgeries contribute to this goal by
decreasing the overall cost of patient care.
Minimally
invasive techniques are associated with lower rates of surgical complications,
such as infections, bleeding, and wound-related issues. Fewer complications
lead to decreased healthcare expenditures related to the treatment of these
complications. Healthcare providers are motivated to adopt minimally invasive
surgical devices to improve patient outcomes and avoid the financial
consequences of managing post-operative complications. Patients who undergo
minimally invasive procedures often experience a faster return to their daily
activities and work, reducing the economic burden of lost productivity. Healthcare
cost containment efforts take into account the indirect costs associated with a
patient's ability to return to work and maintain their quality of life.
Minimally invasive surgeries facilitate this goal by promoting quicker
recoveries.
Download Free Sample Report
Key Market
Challenges
Regulatory
Compliance and Approval Processes
Stringent
regulatory requirements and approval processes can slow down the introduction
of new minimally invasive surgical devices to the market. In the United States,
for instance, the Food and Drug Administration (FDA) requires rigorous testing
and clinical trials to ensure the safety and efficacy of medical devices.
Companies
must invest significant time and resources in navigating the regulatory
pathway, which includes pre-market approvals, 510(k) clearances, and adherence
to Good Manufacturing Practices (GMP). Delays in regulatory approvals can
hinder the timely launch of innovative devices and technologies, impacting
market growth.
Cost
Barriers and Reimbursement Challenges
The
high cost associated with acquiring and implementing minimally invasive
surgical devices can pose a barrier to their widespread adoption. Purchasing
and maintaining advanced surgical equipment, such as robotic-assisted systems,
can strain the budgets of healthcare institutions.
Additionally,
reimbursement policies and rates for minimally invasive procedures may not
always align with the costs incurred by healthcare providers. This can
discourage facilities from investing in these technologies, slowing down market
growth.
Training
and Skill Acquisition
Minimally
invasive surgeries require specialized training and skills that differ from
traditional open procedures. Surgeons and healthcare staff need to undergo
training and certification to proficiently operate these devices.
The
learning curve associated with minimally invasive techniques can be steep, and
healthcare facilities may face challenges in adequately training their staff.
Moreover, recruiting skilled professionals in minimally invasive surgery can be
competitive, which can limit the adoption of these techniques and devices.
Key Market Trends
Robotic-Assisted
Surgery Adoptio
Robotic-assisted
surgical systems, such as the da Vinci Surgical System, are gaining widespread
acceptance in North America. These systems offer enhanced precision and
dexterity to surgeons, making them particularly suitable for complex
procedures.
Surgeons
can perform minimally invasive surgeries with greater control, accuracy, and
smaller incisions, resulting in reduced trauma to patients. This trend is
driving the adoption of robotic-assisted devices in various surgical
specialties, including urology, gynecology, and general surgery. The market is
witnessing the development of next-generation robotic platforms with advanced
capabilities, including augmented reality and artificial intelligence
integration, which further expand their applications.
Telemedicine
and Remote Surgery
Telemedicine
and remote surgery have become increasingly prevalent in North America, driven
by the need to expand healthcare access and improve patient outcomes,
especially in rural or underserved areas.
Surgeons
can perform procedures remotely using robotic surgical systems and real-time
video communication. This trend enables patients to receive specialized care
regardless of their geographic location. As technology advances and regulatory
frameworks evolve to accommodate remote surgical practices, telemedicine and
remote surgery are likely to continue growing, contributing to the adoption of
minimally invasive devices.
Patient-Centric
Care and Personalized Medicine
The
healthcare industry is shifting towards patient-centric care, with a growing
emphasis on personalized medicine. Minimally invasive surgical devices are
playing a crucial role in tailoring treatments to individual patient needs.
Advanced
imaging techniques, such as 3D imaging and augmented reality, allow surgeons to
visualize patient anatomy in greater detail, leading to more precise and
personalized procedures. The development of patient-specific implants and
surgical plans using 3D printing technology is another emerging trend. This
approach ensures a better fit and optimized outcome, particularly in orthopedic
and reconstructive surgeries.
Segmental Insights
Type Insights
Based
on the category of Type, the handheld instruments segment emerged as the
dominant player in the North America market for Minimally Invasive Surgical
Devices in 2022. Handheld instruments encompass a wide range of tools used in
minimally invasive surgeries, such as laparoscopic, endoscopic, and
robotic-assisted procedures. These instruments are versatile and can be
employed across various surgical specialties, including general surgery,
gynecology, urology, and orthopedics. Surgeons rely on handheld instruments
like graspers, scissors, dissectors, and needle holders to perform precise and
delicate tasks during minimally invasive surgeries. The broad spectrum of
applications across different procedures contributes to the dominance of this
segment.
Handheld
instruments have been instrumental in traditional laparoscopic surgeries, which
have a long history of successful implementation in North America. Surgeons are
well-trained in using these instruments for minimally invasive abdominal and
pelvic procedures. Laparoscopic procedures are routinely performed for various
conditions, such as appendectomies, cholecystectomies (gallbladder removal),
and hernia repairs. Handheld instruments are essential tools in these
surgeries, contributing to their widespread adoption.
The
handheld instruments category has not remained stagnant but has seen continuous
innovation and technological advancements. Manufacturers have developed
instruments with improved ergonomics, durability, and precision. Advancements
in materials, such as the use of advanced alloys and coatings, have enhanced
the performance of handheld instruments. Additionally, ergonomic handle designs
and better instrument control have improved surgeon comfort and precision
during procedures. These factors are expected to drive the growth of this
segment.
Surgery
Type Insight
Based
on the category of Surgery Type, the gastrointestinal surgery segment emerged
as the dominant player in the North America market for Minimally Invasive
Surgical Devices in 2022. Gastrointestinal (GI) conditions are highly prevalent
in North America, with a substantial portion of the population experiencing
issues such as acid reflux, gastritis, gallstones, and colorectal disorders. Many
of these conditions require surgical intervention, and minimally invasive
approaches have become the preferred choice due to their associated benefits,
including reduced pain, shorter hospital stays, and quicker recovery times.
The
gastrointestinal surgery category encompasses a wide range of procedures, from
relatively common interventions like laparoscopic cholecystectomy (gallbladder
removal) and appendectomy to more complex surgeries such as colorectal
resections. Minimally invasive techniques have been successfully applied to
these procedures, making them suitable for a broad patient population. Advances
in laparoscopic and endoscopic technologies have significantly enhanced the
feasibility and safety of minimally invasive GI surgeries. Surgeons can access
and visualize the GI tract with high-definition cameras and advanced
instruments. Techniques like laparoscopic colorectal surgery, endoscopic
mucosal resection (EMR) for early-stage GI cancers, and NOTES (natural orifice
transluminal endoscopic surgery) have expanded the scope of minimally invasive
options in the GI field. These factors are expected to drive the growth of this
segment.
End-User
Insights
The
hospital & clinics segment is projected to experience rapid growth during
the forecast period. Hospitals and clinics are the primary centers for surgical
care in North America. They serve as hubs for a wide range of medical
specialties, including surgery.
Most
surgical procedures, both minimally invasive and traditional, are performed
within hospital settings. These facilities house operating rooms, recovery
areas, and the necessary support services for surgical interventions. Hospitals
and clinics typically have access to advanced infrastructure and
state-of-the-art surgical technology. This includes specialized operating rooms
equipped with advanced imaging, robotic surgical systems, and other
cutting-edge surgical devices. The availability of such technology facilitates
the adoption of minimally invasive techniques, as surgeons in hospital settings
are well-equipped to utilize these devices effectively.
Hospitals
employ multidisciplinary surgical teams comprising surgeons, anesthesiologists,
nurses, and support staff with expertise in various surgical specialties. This
collaborative approach ensures that minimally invasive surgeries can be
performed by highly skilled professionals who are trained to use the latest
surgical devices effectively. These factors collectively contribute to the
growth of this segment.
Download Free Sample Report
Regional Insights
United
States emerged as the dominant player in the North America Minimally Invasive
Surgical Devices market in 2022, holding the largest market share in terms of
value. The United States is the dominant force in the North America Minimally
Invasive Surgical Devices Market. The U.S. healthcare market is the largest in
North America, and it accounts for a significant portion of global healthcare
spending. This substantial market size naturally makes it the primary driver of
the Minimally Invasive Surgical Devices Market in the region. The U.S. boasts
some of the most advanced healthcare infrastructure and technology globally.
Its hospitals, clinics, and healthcare institutions are well-equipped to offer
a wide range of minimally invasive surgical procedures, attracting patients
from within and outside the country. U.S. is a hub for medical research and
innovation, fostering the development of cutting-edge minimally invasive
surgical devices and techniques. Leading medical device companies and research
institutions are located in the United States. The United States witnesses high
surgical volumes across various specialties, including cardiovascular surgery,
orthopedics, and oncology, many of which utilize minimally invasive techniques.
The
Canada market is poised to be the fastest-growing market, offering lucrative
growth opportunities for Minimally Invasive Surgical Devices players during the
forecast period. Factors such as Canada has been steadily adopting minimally
invasive surgical techniques and devices, following the trends set by the
United States. Surgeons and healthcare institutions in Canada are increasingly
recognizing the benefits of minimally invasive procedures. Canada has been
making substantial investments in its healthcare system, including the
acquisition of advanced medical technologies and the expansion of healthcare
infrastructure. This investment is likely to drive the adoption of minimally
invasive surgical devices. Like the United States, Canada has an aging
population, which often requires surgical interventions for age-related
conditions. The demand for minimally invasive procedures among older adults is
expected to grow. Canadian patients and healthcare providers have access to
innovative minimally invasive surgical devices and technologies, allowing them
to benefit from the latest advancements in the field. Canada actively
collaborates with international partners and participates in medical research
and innovation, facilitating knowledge sharing and the adoption of best
practices.
Recent Developments
- In
June 2023, Medtronic announced that it had launched its new MiniMed 780G System
in the United States. The MiniMed 780G System is a hybrid closed-loop insulin
pump system that automatically delivers insulin based on blood sugar levels. It
is the first hybrid closed-loop system to be approved by the FDA for people
with type 1 diabetes of all ages.
- In
August 2023, Stryker announced that it had expanded its manufacturing capacity
in North America with the opening of a new plant in Memphis, Tennessee. The new
plant will produce a variety of Stryker's medical device products, including joint
implants, spine implants, and surgical instruments.
- In
August 2023, B. Braun Medical Inc. announced the launch of its new DoseTrac®
Enterprise Infusion Management Software. DoseTrac® Enterprise is a cloud-based
software platform that helps healthcare providers to manage their infusion
therapy programs more efficiently and effectively.
Key Market Players
- Medtronic, Inc.
- Stryker Corporation
- B. Braun Medical Inc.
- Olympus Corporation of the Americas
- Boston Scientific Corporation
- Zimmer Biomet Inc.
- Johnson & Johnson
- Karl Storz Endoscopy-America, Inc.
- Abbott Laboratories
- Philips North America Corporation
|
By Type
|
By Surgery Type
|
By End-User
|
By Region
|
- Handheld Instruments
- Surgical Scopes
- Cutting Instruments
- Guiding Devices
- Electrosurgical Devices
- Others
|
- Cardiovascular
- Gastrointestinal
- Gynecology
- Urology
- Others
|
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
|
- United States
- Canada
- Mexico
|
Report
Scope:
In
this report, the North America Minimally Invasive Surgical Devices Market has
been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- Minimally Invasive Surgical Devices
Market, By
Type:
o Handheld Instruments
o Surgical Scopes
o Cutting Instruments
o Guiding Devices
o Electrosurgical Devices
o Others
- Minimally Invasive Surgical Devices
Market, By Surgery
Type:
o Cardiovascular
o Gastrointestinal
o Gynecology
o Urology
o Others
- Minimally Invasive Surgical Devices
Market, By End-User:
o Hospitals & Clinics
o Ambulatory Surgical Centers
o Others
- Minimally Invasive Surgical Devices
Market, By Region:
o United States
o Canada
o Mexico
Competitive
Landscape
Company
Profiles: Detailed
analysis of the major companies presents in the North America Minimally
Invasive Surgical Devices Market.
Available
Customizations:
North
America Minimally Invasive Surgical Devices market report with the given
market data, Tech Sci Research offers customizations according to a company's
specific needs. The following customization options are available for the
report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
North
America Minimally Invasive Surgical Devices Market is an upcoming report to be
released soon. If you wish an early delivery of this report or want to confirm
the date of release, please contact us at [email protected]